ACT Genomics' Series C Round

ACT Genomics raised a round of funding on September 26, 2018. Investors include CLSA Capital Partners.

ACT Genomics is an integrated cancer molecular information company in Taiwan offering genetic profiling services to cancer research, clinical cancer treatment and drug discovery. ACT Genomics aims to …

Articles about ACT Genomics' Series C Round: